A randomized controlled trial on the effect of Gushukang on bone mineral density in perimenopausal and postmenopausal women | Synapse
April 27, 2026Open Access
A randomized controlled trial on the effect of Gushukang on bone mineral density in perimenopausal and postmenopausal women
Key Points
This trial investigates the effect of Gushukang on bone mineral density in perimenopausal and postmenopausal women.
Randomized controlled trial design
Intervention included Gushukang and hormone therapy for 6 months
Population focused on perimenopausal and postmenopausal women.
Both Gushukang and hormone therapy significantly increase bone mineral density.
Combination therapy shows superior results compared to either treatment alone.
Abstract
Both Gushukang and menopausal hormone therapy for 6 months can increase BMD in perimenopausal and postmenopausal women; however, combination therapy yields superior results.